<+Call for abstracts>

Timeline

14^th September 2026 — Submission system opens
12^th January 2027 — Submission deadline (23:59 PST). No extension.
12^th February 2027 — Notification of acceptance and presentation format (oral or poster)
12^th March 2027 — Registration deadline for presenting authors
21^st April 2027 — Upload deadline for posters and oral-presentation slides
6^th May 2027 — Oral presentations
6^th–8^th May 2027 — Poster presentations (poster sessions across the event)

Who can submit

Anyone may submit. There is no submission fee. The first author must be the presenting author, and must register for the conference and attend in person if the abstract is accepted.

Each person may be first / presenting author on only one abstract. You may be a co-author on any number of others.

No-show, no-publication: the presenting author must register and present the abstract in person, on-site. There is no online or remote presentation option. Accepted abstracts that are not presented on-site will be withdrawn and will not be published.

Tracks

Choose the one track that best fits your work. If your submission spans more than one, then choose the track that best represents the focus or primary contribution of your work. The AIMed Global Forum Research Review Committee may reassign a submission to a different track where it better fits the scope. Authors will be notified of any change.

• Track A — Clinical translation. Original research on preclinical or clinical translation of AI/ML in medicine: real-world implementation, validation, clinical trials and outcomes, or clinical guideline development. This also includes data contributions such as clinical datasets made available to the community and data annotation resources.
• Track B — Methods & development. Original research on AI/ML algorithm and method development with potential clinical application: model development, data-science innovation, and computational methodology. This also includes data contributions such as clinical datasets made available to the community and data annotation resources.
• Track C — Regulatory & translational governance.Original research on regulatory science, approval pathways, standards, post-market surveillance, and safe deployment of medical AI. This could include medicine/health professional curriculum development and training, hospital and health system AI implementation, or regional, national, or international AI policy or change management work. This also includes the regulation of data sharing and access, and frameworks for how health data can be shared.
• Track D — Ethics & patient perspectives.Original research on ethics, fairness, patient involvement, lived experience, consent, and societal impact of medical AI. This also includes patient perspectives on how health data is used and shared.

What to submit

Complete these fields in the submission system. They appear in this order:

1. Title — concise and specific, max 150 characters.
2. Authors and affiliations — full names and affiliations (including country) for all authors; max 2 affiliations per author. Provide contact details for the presenting author and all co-authors.
3. Track — Choose only one of A or B or C or D.
4. Abstract — max 300 words, structured under four headings: Introduction (background, unmet need, aim), Methods (device or method, setting, outcomes, analysis), Results (results available at submission), Summary (key findings, potential impact, limitations). The 300-word limit applies to these four sections only. Authors in non-empirical tracks should interpret Methods and Results as the approach taken and what it showed.
5. Keywords — 3 to 5.
6. References — up to 10, in AMA style (11th edition).
7. Figures and tables — optional; up to 2, uploaded as separate images with captions as text; see below.
8. Disclosures — declare any conflict of interest (e.g. ownership of the product presented), and any use of AI tools in preparing the abstract (see AI use below).

Title, keywords, references, figures/tables, and disclosures are separate fields and do not count toward the 300 words. Write in standard English and define every abbreviation at first use.

You can save a draft and edit your submission as often as you like until the deadline. After the deadline no changes are possible. You can withdraw a submission at any time before the deadline from the submission system; to withdraw after the deadline, contact the Organizing Committee.

Rules for all submissions

• Original work. The abstract must contain original material that has not been published and is not under consideration elsewhere.
• If your work involves humans or animals, it must have ethics-committee approval, and informed consent where relevant. Name the committee and approval number in the Methods. For research with people, follow the Declaration of Helsinki.
• Identifiable patients. Any identifiable patient data or images need written consent for publication. Anonymise where you can. Keep the consent and approval documents yourself and provide them on request; do not upload them.
• Co-authors. The submitting author confirms that all co-authors have seen and approved the abstract. All correspondence goes to the submitting author, who is responsible for informing co-authors.
• After the deadline. The title, author list, and abstract are locked at the submission deadline and cannot be changed. Abstracts are published as submitted, so proofread carefully.

Use of AI

This covers AI used to prepare the abstract (e.g. drafting or editing text, translation, generating figures). AI that is part of your research itself is described normally in the Methods.

• An AI tool cannot be listed as an author.
• You are responsible for the whole abstract, including checking that anything produced with AI is accurate — AI can invent facts and references.
• Disclose any substantive use of AI in preparing the abstract: name the tool and version and say what it was used for.
• Routine tools (spelling, grammar, standard statistical software) do not need to be disclosed.
• Do not use AI to generate or alter scientific figures in a way that misrepresents the data.

Declarations (on the form)

Before you can submit, the submitting author confirms the following as mandatory tick-boxes. Your abstract is incomplete until all are checked.

• The submission guidelines have been read and the submission terms are accepted.
• All co-authors have seen and approved the abstract.
• The presenting (first) author will register and present in person, on-site, if the abstract is accepted. Abstracts not presented on-site are withdrawn and not published.
• The work is original, unpublished, and not under consideration elsewhere.
• Ethics: approval and consent were obtained, or ethics approval does not apply. Any identifiable patient material has written consent for publication.
• All relationships or activities relevant to the work, and any use of AI tools in preparing the abstract, are disclosed in line with BMJ Group’s AI-use policy.
• The abstract is consented for publication in the AIMed Global Forum 2027 Book of Abstracts (BMJ Digital Health & AI), in electronic and hardcopy form, and BMJ Group’s Standard Author Licence for Conference Abstracts is agreed, granting BMJ an exclusive worldwide licence to publish the abstract if it is accepted.

Figures and tables (optional)

Figures and tables are not embedded in the abstract text. You may include a maximum of 2 figures and/or tables in total, each uploaded separately using the two file-upload fields on the form.

• Upload each figure or table as an image file (PNG or TIFF, 300 dpi or higher). Do not embed the caption in the image.
• Enter each caption as text in the caption field next to the upload, starting with its label (e.g. “Figure 1.” or “Table 1.”). Captions do not count toward the 300-word abstract limit.
• Figures and tables are numbered separately: a submission may have both a Figure 1 and a Table 1. Refer to each by its label in the abstract text.
• The abstract must be understandable on its own; figures and tables support it, they don’t replace it.

Review and presentation

Submissions are evaluated by the AIMed Global Forum Research Review Committee. All accepted authors present a poster. From the highest-scoring abstracts, the Scientific Programme Committee selects a subset for oral presentation, taking into account a range of factors — including the aim of representing a diverse set of topics. The top-scoring submissions are additionally shortlisted for the Best Abstract Award(s) and judged on-site (see Awards); both poster and oral presenters are eligible.

• Oral presentations take place on 6 May 2027.
• Posters are displayed on-site for the whole event, and as digital posters on the event website. Depending on the number of accepted posters, there will be one or more dedicated poster sessions.
• Presenting authors must be present at their poster during their assigned poster session to present their work and answer questions.

Publication with BMJ Digital Health & AI

All accepted abstracts that are presented on-site are published in the AIMed Global Forum 2027 Book of Abstracts, produced in collaboration with BMJ Digital Health & AI. Each abstract receives its own DOI.

By submitting, authors consent to publication of the abstract as submitted.

Data protection

Your submission data (author names, affiliations, contact details, and abstract content) is collected by the Polish Institute for Evidence Based Medicine (PIEBM) as data controller, and processed in accordance with the PIEBM privacy policy (piebm.org/privacy-policy/). The submission platform, Oxford Abstracts, acts as our data processor and processes this data on our behalf under its privacy policy (oxfordabstracts.com/privacy-policy). If your abstract is accepted, your data will be transferred to BMJ Group for publication in the Book of Abstracts; this transfer takes place on the basis of applicable law in order to publish your abstract, and you do not need to consent to it separately. BMJ Group processes the data as an independent controller under its privacy notice (bmjgroup.com/privacy-notice).

No-show policy

The presenting author (first author) must register and present the abstract in person, on-site. There is no online or remote presentation option. Abstracts that are not presented on-site are withdrawn: they are not published and receive no DOI. This applies to every accepted abstract.

In exceptional circumstances (for example illness or a visa refusal), a co-author may present in place of the first author, but only with prior written approval from the Organizing Committee. Request this in writing as early as possible.

Awards

The Best Abstract Award(s) are decided in two stages:

• The highest-scoring abstracts, as ranked by the AIMed Global Forum Research Review Committee, are shortlisted for the award(s). The jury visits these posters during the event and talks to the authors. This is separate from the main-stage oral presentations.
• Based on these visits, the on-site jury selects the Best Abstract(s), announced at the conference.

Special Issue invitation. The winning author(s) are invited to submit a full paper to a Special Issue of BMJ Digital Health & AI. The invitation is not a guarantee of publication. Invited manuscript(s) undergo the journal’s standard peer review; the article processing charge (APC) is waived.

Contact

Questions: ai@piebm.org